.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.my news
. august 2, 2017
.
.
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation.
.
.
lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer)
.